EMV Capital CEO Dr. Ilian Iliev talked with Proactive at the One2One Investor Forum about the firm’s investment strategy, operational growth, and future roadmap as a specialist investor in deep tech and life sciences.
Iliev outlined how EMV Capital has grown from £12 million in assets under management (AUM) and 8 portfolio companies in 2020, to over £100 million in AUM and 70 companies by 2026. He further explained that £38 million of this AUM is held directly by the business, while the rest is managed as an FCA-authorised entity.
EMV Capital has built an operating model focused on generating sustainable revenue, including fund management fees, corporate finance services, and value creation fees. In 2024, it achieved over £2 million in revenue, a 67% increase year-on-year, covering 58% of group operating costs. “We now have a platform that is generating recurring revenues from multiple sources,” Iliev stated, highlighting the firm’s focus on scaling to £200 million AUM and achieving exits.
Iliev also discussed their venture build strategy, which involves taking significant stakes in high-potential companies and actively supporting them through financial and operational guidance. Examples include deep tech recycling, healthcare tech, and satellite communications.
#EMVCapital #DeepTechInvesting #LifeSciences #IlianIliev #VentureCapital #PrivateEquity #InvestmentStrategy #TechStartups #NetScientific #Satcom #DigitalHealth #MedTech #InvestorInsights #AUMGrowth #VentureBuilder
